Babylonian Medicine

Freie Universität Berlin

BAM 9 – Assyrian and Babylonian Scholarly Text Catalogues now available for open access via de Gruyter publishing

Assyrian and Babylonian Scholarly Text Catalogues

Medicine, Magic and Divination


We are happy to break the news that the ninth volume of ‘Die babylonisch-assyrische Medizin in Texten und Untersuchungen’ (BAM) is now available for open access on the website of de Gruyter publishing:

It was edited and contributed by BabMed Senior PostDoc Researcher Ulrike Steinert and features further contributions by Francesca Rochberg and Irving L. Finkel as well as of course most of the BabMed team, namely Markham J. Geller, J. Cale Johnson, Strahil V. Panayotov and Eric Schmidtchen.

The reconstruction of ancient Mesopotamian medical, ritual and omen compendia and their complex history is still characterised by many difficulties, debates and gaps due to fragmentary or unpublished evidence. This book offers the first complete edition of the Assur Medical Catalogue, an 8th or 7th century BCE list of therapeutic texts, which forms a core witness for the serialisation of medical compendia in the 1st millennium BCE. The volume presents detailed analyses of this and several other related catalogues of omen series and rituals, constituting the corpora of divination and healing disciplines. The contributions discuss links between catalogues and textual sources, providing new insights into the development of compendia between serialization, standardization and diversity of local traditions. Though its a novel corpus-based approach, this volume revolutionizes the current understanding of Mesopotamian medical texts and the healing disciplines of “conjurer” and “physician”. The research presented here allows one to identify core text corpora for these disciplines, as well as areas of exchange and borrowings between them.

Der Beitrag wurde am Tuesday, den 19. June 2018 um 07:16 Uhr von Till Sören Kappus veröffentlicht und wurde unter Allgemein abgelegt. Sie können die Kommentare zu diesem Eintrag durch den RSS 2.0 Feed verfolgen. Kommentare und Pings sind derzeit nicht erlaubt.

Kommentarfunktion ist deaktiviert